Barclays Maintains Labcorp Holdings at Equal-Weight, Raises Price Target to $380 from $330
Barclays has maintained its Equal-Weight rating on Labcorp Holdings while increasing its price target to $380 from $330.
Stocks · News reference
UBS has raised its price target for Labcorp to $420 from $380 while maintaining a Buy rating.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Barclays has maintained its Equal-Weight rating on Labcorp Holdings while increasing its price target to $380 from $330.
Deutsche Bank has increased its price target for Labcorp to $355 from $306 while maintaining a Hold rating.
Morgan Stanley has revised its price target for Labcorp Holdings, increasing it to $388 from the previous $338.